For more than 40 years a goal that too often has proved elusive is a pharmaceutical defeat of the human immunodeficiency virus—HIV. And the thrust in recent years has emphasized bringing newer, stealthier weapons to the ...
You caught a case of COVID-19 and then you got your first dose of a vaccine. Maybe you now think you are protected from coronavirus infections in the future.
Aug 31, 2021
13
631
Prior infection with coronaviruses that cause the common cold impedes the antibody immune response against SARS-CoV-2, the coronavirus responsible for COVID-19. The results from St. Jude Children's Research Hospital appeared ...
Jan 13, 2022
0
373
Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
Jul 19, 2021
0
345
A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 percent of people generate a robust immune response against COVID-19 after ...
Mar 26, 2021
0
50
People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions—generated less powerful and shorter-lived ...
Nov 19, 2021
0
137
The mRNA vaccines for COVID-19, made by Pfizer/BioNTech and Moderna, are among the most powerful vaccines the world has ever seen. According to clinical trial data, they are more than 94% effective at preventing symptomatic ...
Jul 14, 2021
1
582
Millions of people around the world have received two shots of Sinovac, a Chinese-manufactured inactive vaccine that is used in 48 countries to help reduce transmission rates of COVID-19.
Jan 20, 2022
0
225
A booster dose of the Pfizer–BioNTech vaccine (BNT162b2) against SARS-CoV-2 after an initial two doses of either the CoronaVac inactivated virus vaccine or Pfizer–BioNTech mRNA vaccine is shown to provide protection against ...
Jan 24, 2022
0
27
As the world has witnessed firsthand, SARS-CoV-2, the virus that causes COVID, is difficult to control because of its ability to rapidly mutate and produce many different variants. Scientists at Scripps Research have now ...
Aug 10, 2022
0
151
